President Donald Trump announced a drug pricing deal with Pfizer. Trump announced Pfizer will be offering almost all of its drugs to Medicaid. Pfizer will $70 billion in US manufacturing under a deal made with the Trump administration.
President Donald Trump announced a drug pricing deal with Pfizer. Trump announced Pfizer will be offering almost all of its drugs to Medicaid. Pfizer will $70 billion in US manufacturing under a deal made with the Trump administration.
This site uses Akismet to reduce spam. Learn how your comment data is processed.


| texan59 on General Discussion, Friday, De… | |
| texan59 on General Discussion, Friday, De… | |
| texan59 on General Discussion, Friday, De… | |
| ernnburn on General Discussion, Friday, De… | |
| texan59 on General Discussion, Thursday,… | |
| texan59 on General Discussion, Thursday,… | |
| Stella on What are you cooking for Chris… | |
| WeeWeed on General Discussion, Thursday,… | |
| themellowtraveller on What are you cooking for Chris… | |
| ernnburn on General Discussion, Thursday,… | |
| ernnburn on General Discussion, Thursday,… | |
| WeeWeed on General Discussion, Thursday,… | |
| WeeWeed on General Discussion, Thursday,… | |
| auscitizenmom on Story of the day – My Ch… | |
| auscitizenmom on Minnesota |

ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price).
The agreement will provide every State Medicaid program in the country access to MFN drug prices on Pfizer products, resulting in many millions of dollars in savings and continuing President Trump’s historic efforts to strengthen the program for the most vulnerable.
The agreement ensures foreign nations can no longer use price controls to freeride on American innovation by guaranteeing MFN prices on all new innovative medicines Pfizer brings to market.
The agreement requires Pfizer to repatriate increased foreign revenue on existing products that Pfizer realizes as a result of the President’s strong America First U.S. trade policies for the benefit of American patients.
The agreement requires Pfizer to offer medicines at a deep discount off the list price when selling directly to American patients.
DELIVERING REDUCED COSTS: Today’s actions will result in tangible cost savings to American patients and the healthcare system as a whole. Taken together, more than 100 million patients are impacted by the diseases Pfizer’s medicines treat, and many of those will benefit from the President’s successful negotiation of lower prices for Americans.
LikeLiked by 2 people
I hope they aren’t doing the rope-a-dope on this. I heard something a couple weeks ago stating that if we had a cost of $500 here and $100 in Europe, what would happen is that they would be raising the price in Europe to $300 and lower ours to $300. We still get some benefit, but pharma isn’t gonna lose a nickel. Not sure that I agree with it, but it’s better than where we are. half-a-loaf is better than none……….
LikeLiked by 2 people
That occurred to me too. I guess we will see.
LikeLiked by 1 person